Table 4. Follow up of non-malignant cases plus number of procedures during the follow-up period of 6 months.
| Patient number | FNB | EUS + Biopsy | LUS + Biopsy | CT |
Final
diagnosis |
| 4 | Benign (suspicion of leiomyomatous tumor) | – | + | + | Leiomyoma |
| 5 | Benign (IPMN with LGD) | + + | – | + + | IPMN – LGD |
| 6 | Benign (pancreatitis) | – | – | + | Pancreatitis |
| 13 | Benign (pancreatitis) | + | + | + | Pancreatitis |
| 15 | Atypical (fibrosis) | – | + | – | Adenocarcinoma |
| 16 | Non-tissue (blood clots) | + | – | – | Adenocarcinoma |
| 19 1 | Benign (fibrosis) | + | – | + + | PANIN-2 |
| 25 | Suspicion of malignancy (HGD) | + | – | – | Adenocarcinoma |
| 28 | Benign (fibrosis) | – | – | + | Pancreatitis |
| 34 | Suspicion of malignancy (IPMN) | + + | – | + + | PANIN |
| 35 | Benign (normal tissue) | + (– biopsy) | – | + + | Normal pancreas |
| 40 | Benign (IPMN with LGD) | + + | – | + + | IPMN – LGD |
CT, computed tomography; EUS, endoscopic ultrasound; FNB, fine-needle biopsy; HGD, high-grade dysplasia; IPMN, intraductal papillary mucinous neoplasm; LGD, low-grade dysplasia; LUS, laparoscopic ultrasound; PAN IN, pancreatic intraepithelial neoplasia
1
The surveillance was stopped after 3 months due to severer psychiatric disease.